AMAgnieszka Markiewicz

Agnieszka Markiewicz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Agnieszka Markiewicz has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Agnieszka Owczarczyk-Saczonek

    Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, School of Medicine, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland

    2 shared publications
  • Agnieszka B. Owczarczyk-Saczonek

    Department of Dermatology Sexually Transmitted Diseases and Clinical Immunology Medical College University of Warmia and Mazury Olsztyn Poland

    1 shared publication
  • Agnieszka Barbara Owczarczyk-Saczonek

    Univ Warmia & Mazury, Dept & Clin Dermatol Sexually Transmitted Dis & C, Olsztyn, Poland

    1 shared publication
  • Aleksandra Kocbach-Przudzik

    Clinical Department of Infectious Diseases in Ostroda Medical College University of Warmia and Mazury Olsztyn Poland

    1 shared publication
  • Aleksandra Skórka

    Students Organization, Department and Clinic of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, University of Warmia and Mazury, 10-229 Olsztyn, Poland

    1 shared publication
  • Anna Botulińska

    Clinical Department of Infectious Diseases in Ostroda Medical College University of Warmia and Mazury Olsztyn Poland

    1 shared publication

Latest Publications

  • Open Access

    Atypical Blistering Manifestation of Secondary Syphilis: Case Report and Review of Reported Cases

    by Agnieszka Markiewicz, Aleksandra Skórka, Agnieszka Owczarczyk-Saczonek

    Background/Objectives: Secondary syphilis typically presents with a non-pruritic maculopapular rash. However, vesicular and bullous manifestations are exceedingly rare in adults and may mimic autoimmune blistering diseases. The objective of this report is to describe atypical presentation of secondary syphilis with predominant vesiculobullous lesions and to emphasize the importance of including syphilis in the differential diagnosis of blistering skin diseases. Methods: We describe the case of a 46-year-old bisexual man with syphilis of unknown duration who presented with recurrent polymorphic skin eruptions, predominantly bullous and vesicular in nature. Clinical examination, serologic testing, and histopathologic evaluation were performed to establish the diagnosis. Results: Serologic tests confirmed active syphilis infection. A brief review of similar reported cases was conducted to highlight the clinical variability of vesiculobullous syphilis. Conclusions: Atypical vesiculobullous presentations of secondary syphilis pose significant diagnostic challenges and may be mistaken for autoimmune blistering disorders. Clinicians should maintain a high index of suspicion for syphilis in patients with polymorphic or blistering eruptions, particularly in those with risk factors for sexually transmitted infections. Awareness of these uncommon manifestations can facilitate timely diagnosis and appropriate treatment.


  • Open Access

    mRNA expression of caspase 14 in skin epithelial malignancies

    by Agnieszka Markiewicz, Dawid Sigorski, Mateusz Markiewicz, Waldemar J. Placek, Agnieszka Barbara Owczarczyk-Saczonek

    Introduction: The skin is the largest organ in the human body and it is also a complex organ. Its protective function is properly maintained due to its continuous renewal. Malignancies develop when the balance between proliferation and cell death is dysregulated in skin cells. Skin epithelial...


  • Open Access

    Tolerability of the BNT162b2 COVID-19 Vaccine during Pregnancy among Polish Healthcare Professionals

    by Wojciech Zdanowski, Agnieszka Markiewicz, Natalia Zdanowska, Janina Lipińska, Tomasz Waśniewski

    The tolerance and safety of vaccination in pregnancy should be assessed in local populations based on ethnic differences across countries. Therefore, this study aimed to determine the tolerability of the BNT162b2 mRNA vaccination in pregnancy in a Polish population. An online questionnaire enquiring about the safety and tolerability of the BNT162b2 mRNA vaccine was distributed to pregnant and non-pregnant female healthcare professionals who had voluntarily received one or two doses of the COVID-19 vaccine in Poland. The two groups were compared simultaneously considering the COVID-19 infection status before vaccination. Compared with that noted in the control group, pregnant women in the COVID-19-free group were less likely to have fever (p = 0.002) or gastrointestinal symptoms (p = 0.009) after the second dose. In the COVID-19-exposed group, pregnant women were less likely to experience local skin reactions (p = 0.009), and myalgia (p = 0.003) after the first dose. After the second dose, the only noticeable difference was a lower incidence of myalgia (p = 0.001) in pregnant women. The tolerability of the BNT162b2 mRNA COVID-19 vaccine was similar in both the groups. No severe local, generalised, or pregnancy complications related to mother or foetus were observed. Good tolerability of the BNT162b2 mRNA COVID-19 vaccine in pregnancy in the Polish population may facilitate the decision to vaccinate pregnant women against COVID-19.


  • Open Access

    Caspase-14—From Biomolecular Basics to Clinical Approach. A Review of Available Data

    by Agnieszka Markiewicz, Dawid Sigorski, Mateusz Markiewicz, Agnieszka Owczarczyk-Saczonek, Waldemar Placek

    Caspase-14 is a unique member of the caspase family—a family of molecules participating in apoptosis. However, it does not affect this process but regulates another form of programmed cell death—cornification, which is characteristic of the epidermis. Therefore, it plays a crucial role in the formation of the skin barrier. The cell death cycle has been a subject of interest for researchers for decades, so a lot of research has been done to expand the understanding of caspase-14, its role in cell homeostasis and processes affecting its expression and activation. Conversely, it is also an interesting target for clinical researchers searching for its role in the physiology of healthy individuals and its pathophysiology in particular diseases. A summary was done in 2008 by Denecker et al., concentrating mostly on the biotechnological aspects of the molecule and its physiological role. However, a lot of new data have been reported, and some more practical and clinical research has been conducted since then. The majority of studies tackled the issue of clinical data presenting the role of caspase in the etiopathology of many diseases such as retinal dysfunctions, multiple malignancies, and skin conditions. This review summarizes the available knowledge on the molecular and, more interestingly, the clinical aspects of caspase-14. It also presents how theoretical science may pave the way for medical research. Methods: The authors analyzed publications available on PubMed until 21 March 2021, using the search term “caspase 14”.


  • Open Access

    Erythema migrans – diagnostic challenges, procedures, and treatment

    by Aleksandra Kocbach-Przudzik, Anna Botulińska, Agnieszka Markiewicz, Agnieszka B. Owczarczyk-Saczonek, Piotr Kocbach

    Lyme borreliosis is the most known and frequent disease caused by ticks. This disease may be limited to the skin, involve muscle and articular system, the heart, or the nervous system. Erythema migrans is a skin manifestation of an early Lyme borreliosis. Physicians specializing in infectious...